| Literature DB >> 24143178 |
José Claudio Provenzano1, José F Siqueira, Isabela N Rôças, Romênia R Domingues, Adriana F Paes Leme, Márcia R S Silva.
Abstract
Analysis of the metaproteome of microbial communities is important to provide an insight of community physiology and pathogenicity. This study evaluated the metaproteome of endodontic infections associated with acute apical abscesses and asymptomatic apical periodontitis lesions. Proteins persisting or expressed after root canal treatment were also evaluated. Finally, human proteins associated with these infections were identified. Samples were taken from root canals of teeth with asymptomatic apical periodontitis before and after chemomechanical treatment using either NaOCl or chlorhexidine as the irrigant. Samples from abscesses were taken by aspiration of the purulent exudate. Clinical samples were processed for analysis of the exoproteome by using two complementary mass spectrometry platforms: nanoflow liquid chromatography coupled with linear ion trap quadrupole Velos Orbitrap and liquid chromatography-quadrupole time-of-flight. A total of 308 proteins of microbial origin were identified. The number of proteins in abscesses was higher than in asymptomatic cases. In canals irrigated with chlorhexidine, the number of identified proteins decreased substantially, while in the NaOCl group the number of proteins increased. The large majority of microbial proteins found in endodontic samples were related to metabolic and housekeeping processes, including protein synthesis, energy metabolism and DNA processes. Moreover, several other proteins related to pathogenicity and resistance/survival were found, including proteins involved with adhesion, biofilm formation and antibiotic resistance, stress proteins, exotoxins, invasins, proteases and endopeptidases (mostly in abscesses), and an archaeal protein linked to methane production. The majority of human proteins detected were related to cellular processes and metabolism, as well as immune defense. Interrogation of the metaproteome of endodontic microbial communities provides information on the physiology and pathogenicity of the community at the time of sampling. There is a growing need for expanded and more curated protein databases that permit more accurate identifications of proteins in metaproteomic studies.Entities:
Mesh:
Year: 2013 PMID: 24143178 PMCID: PMC3797121 DOI: 10.1371/journal.pone.0076108
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Overall number of microbial proteins identified in symptomatic and asymptomatic (initial) endodontic infections.
| Protein (functional class) | Abscess cases | Asymptomatic cases |
| Transcription and translation | 30 | 16 |
| Cell division/peptidoglycan synthesis | 4 | 6 |
| Chemotaxis | 1 | 1 |
| DNA process | 18 | 10 |
| Energy metabolism | 21 | 9 |
| Fatty acid metabolism | 5 | 1 |
| Methanogenesis | 0 | 1 |
| Membrane | 10 | 1 |
| Nucleotide metabolism | 8 | 3 |
| Antibiotic resistance | 0 | 2 |
| Adhesion | 1 | 1 |
| Pathogenesis/virulence | 1 | 1 |
| Proteolysis | 6 | 1 |
| Stress response | 3 | 6 |
| Transport | 9 | 5 |
| Vitamin Biosynthesis | 3 | 0 |
| Other/unknown | 53 | 24 |
| Total | 173 | 88 |
Classification of microbial proteins identified in different clinical samples.
| Protein (functional class) | Abscess 1 | Abscess 2 | S1 CHX | S2 CHX | S1 NaOCl | S2 NaOCl |
| Transcription and translation | 14 | 16 | 13 | 6 | 3 | 6 |
| Cell division/Peptidoglycan synthesis | 2 | 2 | 5 | 1 | 1 | 3 |
| Chemotaxis | 1 | 0 | 1 | 0 | 0 | 0 |
| DNA process | 10 | 8 | 9 | 7 | 1 | 2 |
| Energy metabolism | 13 | 8 | 8 | 3 | 1 | 4 |
| Fatty Acid Metabolism | 0 | 5 | 1 | 2 | 0 | 1 |
| Methanogenesis | 0 | 0 | 0 | 0 | 1 | 0 |
| Membrane | 5 | 5 | 1 | 1 | 0 | 2 |
| Nucleotide metabolism | 4 | 4 | 3 | 2 | 0 | 1 |
| Antibiotic Resitence | 0 | 0 | 2 | 0 | 0 | 0 |
| Adhesion | 0 | 1 | 0 | 0 | 1 | 1 |
| Pathogenesis/Virulence | 1 | 0 | 1 | 0 | 0 | 1 |
| Proteolysis | 2 | 4 | 1 | 0 | 0 | 1 |
| Stress Response | 2 | 1 | 5 | 1 | 0 | 2 |
| Transport | 4 | 5 | 6 | 0 | 0 | 0 |
| Vitamin Biosynthesis | 3 | 0 | 0 | 1 | 0 | 1 |
S1, pool of 6 initial samples from asymptomatic cases.
S2, pool of 6 samples from asymptomatic cases taken after treatment.
CHX, chlorexidine used as the irrigant.
NaOCl, sodium hypochlorite used as the irrigant.
Microbial proteins involved in pathogenicity and resistance/survival detected in samples from endodontic infections.
| Protein | Accession number (Uniprot) | Biological Function | Sample |
|
| |||
| Putative invasin | D3UXC7 | Virulence | Abscess |
| Streptopain | SPEB_STRP1 (+2) | Virulence | Initial (asymptomatic) |
| Putative NAD(+)-arginine ADP-ribosyltransferase Mav (toxin) | MAV_MYCA1 | Virulence | Post-treatment (NaOCl) |
| Glycosyl transferase group 1 | D1CAK5 | Adhesion | Initial (asymptomatic) |
| Tight adherence protein G | D9PEH5_ACTPL (+1) | Adhesion | Post-treatment (NaOCl) |
| Coagulation factor 5/8 type domain protein | B2UQE4 | Adhesion | Abscess |
| ATP-dependent zinc metalloprotease FtsH | FTSH_HALOH | Proteolysis | Abscess |
| Collagenase A | F7J0G5_CLOPF (+1) | Proteolysis | Abscess |
| Endopeptidase | Q5KFP6_CRYNJ | Proteolysis | Initial (asymptomatic) |
| Oligoendopeptidase F | A3GZW8_VIBCL | Proteolysis | Abscess |
| Protease HtpX homolog | HTPX_POLNS | Proteolysis | Abscess |
| Minor extracellular protease vpr | F5SFT5 | Proteolysis | Abscess |
| Subtilisin-like serine protease | J0P971 | Proteolysis | Abscess |
| IgA-specific serine endopeptidase | I0Q8W0 | Proteolysis | Post-treatment (NaOCl) |
|
| |||
| TetR family transcriptional regulator | I5BER7 | Antibiotic resistance | Initial (asymptomatic) |
| Beta-lactamase | H5V6X6 | Antibiotic resistance | Initial (asymptomatic) |
| Anti-sigma F factor | SP2AB_BACSU | Stress response | Initial (asymptomatic) |
| 60 kDa chaperonin (GroEL - HSP 60) | CH60_NEIFL (+6) | Stress response, virulence | Initial (asymptomatic) |
| Alkyl hydroperoxide reductase | A7NHN0 | Stress response | Abscess |
| ATP-dependent protease ATPase subunit HslU | HSLU_DESAD (+1) | Stress response | Initial (asymptomatic) |
| Catalase | Q82ID4 | Stress response | Post-treatment (CHX) |
| Periplasmic sensor signal transduction histidine kinase | Q11JY3 | Stress response | Initial (asymptomatic) |
| Chaperone protein DnaK (HSP 70) | DNAK_DECAR/HTPG_BORA1 | Stress response, virulence | Post-treatment (NaOCl) |
| Putative toxin-antitoxin system, toxin component | D9WI88 | Stress response, biofilm formation | Abscess |
| Tetratricopeptide TPR_2 repeat protein | C7QUV7 | Stress response | Initial (asymptomatic) |
| Transport associated protein | B5HF16 | Stress response | Initial (asymptomatic) |
| Quinone oxidoreductase | I6AH03 | Stress response | Post-treatment (NaOCl) |
| ATP-dependent helicase/nuclease subunit A | ADDA_LACPL | Dna repair | Post-treatment (CHX) |
| Dihydroneopterin triphosphate pyrophosphatase | F0GE57 | Dna repair | Initial (asymptomatic);post-treatment (CHX) |
| DNA ligase | DNLJ_ACHLI | Dna repair | Abscess |
| Holliday junction ATP-dependent DNA helicase RuvB | I4ECD9 | Dna repair | Abscess |
| Probable DNA ligase | DNLI_SACEN (+1) | Dna repair | Abscess |
| Probable endonuclease 4 | D3L2G4 | Dna repair | Abscess |
| Protein RecA | RECA_PARDE (+3) | Dna repair | Abscess |
| Putative uncharacterized protein | G5HGC1 | Dna repair | Abscess, post-treatment (CHX) |
| UPF0758 protein NT01CX_1687 | Y1687_CLONN | Dna repair | Initial (asymptomatic) |
| UvrABC system protein B | UVRB_PSYIN | Dna repair | Abscess |
| UvrABC system protein C | A3VEV1 | Dna repair | Initial (asymptomatic) |
| A/G-specific adenine glycosylase | E8XRQ6 | Dna repair | Abscess |
Human proteins involved in host defense mechanisms detected in samples from endodontic infections.
| Host defense proteins | Accession number (Uniprot) | Biological function | Sample |
| 60 kDa heat shock protein, mitochondrial | P10809 | Stress response | Post-treatment (NaOCl) |
| Aldehyde oxidase | Q06278 | Inflammatory response, reactive oxygen species metabolic process | Abscess |
| Complement C3 | P01024 | Complement activation | Abscess |
| Cystatin-S | CYTS_HUMAN | Protease inhibitor | Initial (asymptomatic); post-treatment (CHX/NaOCl) |
| Cystatin-SA | CYTT_HUMAN | Protease inhibitor | Initial (asymptomatic); post-treatment (NaOCl) |
| Cystatin-SN | CYTN_HUMAN/P01037 | Protease inhibitor | Abscess; initial (asymptomatic); post-treatment (CHX/NaOCl) |
| Cytotoxic T-lymphocyte protein 4 | P16410 | Adaptive immunity | Abscess |
| G2/mitotic-specific cyclin-B2 | O95067 | T cell homeostasis | Abscess |
| Haptoglobin | HPT_HUMAN (+5)/P00738 | Acute-phase response | Abscess; initial (asymptomatic) |
| Histone H2B type F-S | P57053 | Defense response to bacterial infection | Abscess; initial (asymptomatic) |
| Ig alpha-1 chain C region | P01876 | Adaptive immunity, antigen binding | Initial (asymptomatic) |
| Ig gamma-3 chain C region | IGHG3_HUMAN/P01860 | Adaptive immunity, Fc-gamma receptor signaling pathway involved in phagocytosis | Abscess; initial (asymptomatic); post-treatment (NaOCl) |
| Ig kappa chain C region | IGKC_HUMAN (+7)/P01834 | Adaptive immunity, Fc-gamma receptor signaling pathway involved in phagocytosis | Abscess; initial (asymptomatic); post-treatment (CHX/NaOCl) |
| Ig lambda chain C regions | P01842 | Adaptive immunity, Fc-gamma receptor signaling pathway involved in phagocytosis | Abscess; initial (asymptomatic) |
| Interleukin enhancer-binding factor 2 | Q12905 | Immune response | Post-treatment (NaOCl) |
| Lymphoid-specific helicase | HELLS_HUMAN | Lymphocyte proliferation | Abscess |
| Lymphokine-activated killer T-cell-originated protein kinase | Q96KB5 | Lymphocyte cell activation | Abscess |
| Myeloperoxidase | P05164 | Respiratory burst involved in defense response | Abscess |
| Neutrophil cytosol factor 4 | Q15080 | Antigen processing and presentation of exogenous peptide antigen via MHC class I | Abscess |
| Neutrophil defensin 1 | DEF1_HUMAN (+1)/P59665 | Defense response to bacterial infection, chemotaxis | Abscess; initial (asymptomatic); post-treatment (NaOCl) |
| Neutrophil defensin 3 | P59666 | Defense response to bacterial infection | Abscess; initial (asymptomatic); post-treatment (NaOCl) |
| Polymeric immunoglobulin receptor | PIGR_HUMAN | IgA and IgM receptor | Initial (asymptomatic); post-treatment (CHX/NaOCl) |
| Prolactin-inducible protein | PIP_HUMAN | Expressed in pathological conditions | Initial (asymptomatic); post-treatment (NaOCl) |
| Protein S100-A9 | P06702 | Chronic inflammatory response, defense response to bacterial infection, chemokine production, response to lipopolysaccharide | Initial (asymptomatic) |